Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2023

Helfgott DC, Racine-Brzostek S, Short KJ, Zhao Z, Christos P, Nino I, et al. Immunogenicity of COVID-19 mRNA vaccines in patients with acute myeloid leukemia and myelodysplastic syndrome. Leuk Lymphoma. 2023;64(3):662-670.

Barbhaiya M, Zuily S, Naden R, Hendry A, Manneville F, Amigo M-, et al. The 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria. Arthritis Rheumatol. 2023;75(10):1687-1702.

Aguilar R, Khan L, Arslanovic N, Birmingham K, Kasliwal K, Posnikoff S, et al. Multivalent binding of the tardigrade Dsup protein to chromatin promotes yeast survival and longevity upon exposure to oxidative damage. Res Sq. 2023.

Guahmich NL, Man L, Wang J, Arazi L, Kallinos E, Topper-Kroog A, et al. Human theca arises from ovarian stroma and is comprised of three discrete subtypes. Commun Biol. 2023;6(1):7.

Rogerson D, Alkelai A, Giordano J, Pantrangi M, Hsiao M-, Nhan-Chang C-, et al. Investigation into the genetics of fetal congenital lymphatic anomalies. Prenat Diagn. 2023;43(6):703-716.

Sasset L, Manzo OL, Zhang Y, Marino A, Rubinelli L, Riemma MA, et al. Nogo-A reduces ceramide de novo biosynthesis to protect from heart failure. Cardiovasc Res. 2023;119(2):506-519.

Dameri M, Cirmena G, Ravera F, Ferrando L, Cuccarolo P, Stabile M, et al. Standard Operating Procedures (SOPs) for non-invasive multiple biomarkers detection in an academic setting: A critical review of the literature for the RENOVATE study protocol. Crit Rev Oncol Hematol. 2023;185:103963.

Miller RC, Magro CM, Melnick LE, Lipner SR. Acral Fibrochondromyxoid Tumor Presenting as Enlarging Nodule Involving the Distal Fingertip and Hyponychium: A Case Report. Case Rep Dermatol. 2023;15(1):56-61.

Suknuntha K, Geyer JT, Patel KP, Weinberg OK, Rogers HJ, Lake JI, et al. Clinicopathologic characteristics of myeloproliferative neoplasms with JAK2 exon 12 mutation. Leuk Res. 2023;127:107033.

2022

Larsson PF, Karlsson R, Sarwar M, Miftakhova R, Wang T, Khaja AS, et al. FcγRIIIa receptor interacts with androgen receptor and PIP5K1α to promote growth and metastasis of prostate cancer. Mol Oncol. 2022;16(13):2496-2517.